Synthesis and Characterization of 1:2 Complex of Mercury(II) Chloride with 1,3-Dimethyl-1H-Imidazole-2(3H)-Thione

Cytoprotective effects of imidazole-based [S1] and [S2]-donor ligands against mercury toxicity: a bioinorganic approach

Here we report the coordination behaviour of an imidazole-based [S1]-donor ligand, 1,3-dimethyl-imidazole-2(3H)-thione (L1), and [S2]-donor ligand, 3,3'-methylenebis(1-methyl-imidazole-2(3H)-thione) (L2) or 4,4'-(3,3'-methylenebis-(2-thioxo-2,3-dihydro-imidazole-3,1-diyl))dibutanoic acid (L3), with HgX2 (X = Cl, Br or I) in solution and the solid state. NMR, UV-Vis spectroscopic, and single crystal X-ray studies demonstrated that L1 or L2 coordinated rapidly and reversibly to the mercury center of HgX2 through the thione moiety. Treatment of L2 with HgCl2 or HgBr2 afforded 16-membered metallacycle k1-(L2)2Hg2Cl4 or k1-(L2)2Hg2Br4 where two Cl or Br atoms are located inside the ring. In contrast, treatment of L2 with HgI2 afforded a chain-like structure of k1-[L2Hgl2]n, possibly due to the large size of the iodine atom. Interestingly, [S1] and [S2]-donor ligands (L1, L2, and L3) showed an excellent efficacy to protect liver cells against HgCl2 induced toxicity and the strength of their efficacy is in the order of L3 > L2 > L1. 30% decrease of ROS production was observed when liver cells were co-treated with HgCl2 and L1 in comparison to those cells treated with HgCl2 only. In contrast, 45% and 60% decrease of ROS production was observed in the case of cells co-treated with HgCl2 and thiones L2 and L3, respectively, indicating that [S2]-donor ligands L2 and L3 have better cytoprotective effects against oxidative stress induced by HgCl2 than [S1]-donor ligand L1. Water-soluble ligand L3 with N-(CH2)3CO2H substituents showed a better cytoprotective effect against HgCl2 toxicity than L2 in liver cells.

Methylmercury's chemistry: From the environment to the mammalian brain

Methylmercury is a neurotoxicant that is found in fish and rice. MeHg's toxicity is mediated by blockage of -SH and -SeH groups of proteins. However, the identification of MeHg's targets is elusive. Here we focus on the chemistry of MeHg in the abiotic and biotic environment. The toxicological chemistry of MeHg is complex in metazoans, but at the atomic level it can be explained by exchange reactions of MeHg bound to -S(e)H with another free -S(e)H group (R¹S(e)-HgMe + R²-S(e)H ↔ R¹S(e)H + R²-S(e)-HgMe). This reaction was first studied by professor Rabenstein and here it is referred as the "Rabenstein's Reaction". The absorption, distribution, and excretion of MeHg in the environment and in the body of animals will be dictated by Rabenstein's reactions. The affinity of MeHg by thiol and selenol groups and the exchange of MeHg by Rabenstein's Reaction (which is a diffusion controlled reaction) dictates MeHg's neurotoxicity. However, it is important to emphasize that the MeHg exchange reaction velocity with different types of thiol- and selenol-containing proteins will also depend on protein-specific structural and thermodynamical factors. New experimental approaches and detailed studies about the Rabenstein's reaction between MeHg with low molecular mass thiol (LMM-SH) molecules (cysteine, GSH, acetyl-CoA, lipoate, homocysteine) with abundant high molecular mass thiol (HMM-SH) molecules (albumin, hemoglobin) and HMM-SeH (GPxs, Selenoprotein P, TrxR1-3) are needed. The study of MeHg migration from -S(e)-Hg- bonds to free -S(e)H groups (Rabenstein's Reaction) in pure chemical systems and neural cells (with special emphasis to the LMM-SH and HMM-S(e)H molecules cited above) will be critical to developing realistic constants to be used in silico models that will predict the distribution of MeHg in humans.